Author

P. Singh

Observed name: Parminder Singh

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital

Observed institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona)

OpenAlex ID: A5013754031

Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy

2026 · Parminder Singh, Seth P. Lerner · New England Journal of Medicine · 3

1417P Mixed treatment comparisons evaluating contemporary therapies in metastatic castration sensitive prostate cancer (mCSPC): A living systematic review

2022 · I.B. Riaz, S.A.A. Naqvi, et al. · Annals of Oncology

Works count: 2

Citation count: 3

H-index: 1

I10-index: